These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21321234)

  • 21. Peptide mimics of SNARE transmembrane segments drive membrane fusion depending on their conformational plasticity.
    Langosch D; Crane JM; Brosig B; Hellwig A; Tamm LK; Reed J
    J Mol Biol; 2001 Aug; 311(4):709-21. PubMed ID: 11518525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes.
    Rapaport D; Shai Y
    J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin. Implication of the necessity of a helix-hinge-helix motif in fusion activity.
    Hsu CH; Wu SH; Chang DK; Chen C
    J Biol Chem; 2002 Jun; 277(25):22725-33. PubMed ID: 11937502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers.
    Vaccaro L; Cross KJ; Kleinjung J; Straus SK; Thomas DJ; Wharton SA; Skehel JJ; Fraternali F
    Biophys J; 2005 Jan; 88(1):25-36. PubMed ID: 15475582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
    Mobley PW; Barry JA; Waring AJ; Sherman MA; Gordon LM
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):224-42. PubMed ID: 17331029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
    Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
    J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.
    Samuel O; Shai Y
    Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.
    Pillot T; Goethals M; Vanloo B; Talussot C; Brasseur R; Vandekerckhove J; Rosseneu M; Lins L
    J Biol Chem; 1996 Nov; 271(46):28757-65. PubMed ID: 8910517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix.
    Vázquez MI; Rivas G; Cregut D; Serrano L; Esteban M
    J Virol; 1998 Dec; 72(12):10126-37. PubMed ID: 9811753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmembrane Domain Dissociation Is Required for Hendra Virus F Protein Fusogenic Activity.
    Slaughter KB; Dutch RE
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.
    Porotto M; Rockx B; Yokoyama CC; Talekar A; Devito I; Palermo LM; Liu J; Cortese R; Lu M; Feldmann H; Pessi A; Moscona A
    PLoS Pathog; 2010 Oct; 6(10):e1001168. PubMed ID: 21060819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.
    Wexler-Cohen Y; Johnson BT; Puri A; Blumenthal R; Shai Y
    J Biol Chem; 2006 Apr; 281(14):9005-10. PubMed ID: 16455666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Boomerang'-like insertion of a fusogenic peptide in a lipid membrane revealed by solid-state 19F NMR.
    Afonin S; Dürr UH; Glaser RW; Ulrich AS
    Magn Reson Chem; 2004 Feb; 42(2):195-203. PubMed ID: 14745800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Architecture of the hepatitis C virus E1 glycoprotein transmembrane domain studied by NMR.
    Zazrin H; Shaked H; Chill JH
    Biochim Biophys Acta; 2014 Mar; 1838(3):784-92. PubMed ID: 24192053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin.
    Han X; Bushweller JH; Cafiso DS; Tamm LK
    Nat Struct Biol; 2001 Aug; 8(8):715-20. PubMed ID: 11473264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimeric transmembrane domain interactions in paramyxovirus fusion proteins: roles in protein folding, stability, and function.
    Smith EC; Smith SE; Carter JR; Webb SR; Gibson KM; Hellman LM; Fried MG; Dutch RE
    J Biol Chem; 2013 Dec; 288(50):35726-35. PubMed ID: 24178297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
    Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state.
    Russell CJ; Jardetzky TS; Lamb RA
    J Virol; 2004 Dec; 78(24):13727-42. PubMed ID: 15564482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-dependent conformational changes of membrane-bound Ebola fusion peptide drive vesicle fusion.
    Suárez T; Gómara MJ; Goñi FM; Mingarro I; Muga A; Pérez-Payá E; Nieva JL
    FEBS Lett; 2003 Jan; 535(1-3):23-8. PubMed ID: 12560072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for paramyxovirus-mediated membrane fusion.
    Baker KA; Dutch RE; Lamb RA; Jardetzky TS
    Mol Cell; 1999 Mar; 3(3):309-19. PubMed ID: 10198633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.